학술논문
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)
Document Type
Article
Author
Nakamura, Y.; Namikawa, K.; Yoshikawa, S.; Kiniwa, Y.; Maekawa, T.; Yamasaki, O.; Isei, T.; Matsushita, S.; Nomura, M.; Nakai, Y.; Fukushima, S.; Saito, S.; Takenouchi, T.; Tanaka, R.; Kato, H.; Otsuka, A.; Matsuya, T.; Baba, N.; Nagase, K.; Inozume, T.; Fujimoto, N.; Kuwatsuka, Y.; Onishi, M.; Kaneko, T.; Onuma, T.; Umeda, Y.; Ogata, D.; Takahashi, A.; Otsuka, M.; Teramoto, Y.; Yamazaki, N.
Source
In ESMO Open December 2021 6(6)
Subject
Language
ISSN
2059-7029